반응식
[C:1]([C:3]1[CH:4]=[CH:5][C:6]([O:14][CH3:15])=[C:7](/[CH:9]=[CH:10]/[C:11]([OH:13])=O)[CH:8]=1)#[N:2].F[B-](F)(F)F.N1(OC(N(C)C)=[N+](C)C)C2C=C[CH:28]=[CH:29][C:24]=2N=N1.[CH:38](N(C(C)C)CC)(C)C.[NH2:47][C@@H:48]([CH2:54][N:55]1[CH2:60][CH2:59][CH:58]([O:61][C:62]2[CH:67]=[CH:66][C:65]([F:68])=[CH:64][CH:63]=2)[CH2:57][CH2:56]1)[CH2:49][NH:50][C:51](=[O:53])[OH:52]>C(Cl)Cl>[C:29]([O:53][C:51](=[O:52])[NH:50][CH2:49][C@@H:48]([NH:47][C:11](=[O:13])/[CH:10]=[CH:9]/[C:7]1[CH:8]=[C:3]([C:1]#[N:2])[CH:4]=[CH:5][C:6]=1[O:14][CH3:15])[CH2:54][N:55]1[CH2:56][CH2:57][CH:58]([O:61][C:62]2[CH:67]=[CH:66][C:65]([F:68])=[CH:64][CH:63]=2)[CH2:59][CH2:60]1)([CH3:28])([CH3:24])[CH3:38]참가 물질
반응물 4
생성물 1
시약·촉매·용매 1
실험 절차
A solution of (E)-3-(5-cyano-2-methoxy-phenyl)-acrylic acid (0.36 g, 1.77 mmol), 2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyl-uronium tetrafluoroborate (1.01 g, 2.65 mmol) and diisopropylethylamine (0.46 ml, 2.65 mmol) in DCM (15 ml) is treated with a solution of {(R)-2-Amino-3-[4-(4-fluoro-phenoxy)-piperidin-1-yl]-propyl}-carbamic acid .tert.-butyl ester (0.65 g, 1.77 mmol) in DCM (5 ml). The reaction mixture is stirred at ambient temperature for 30 minutes, then washed with saturated aqueous NaHCO3, water and brine. The DCM phase is dried over MgSO4 and evaporated. The crude product is purified by flash silica chromatography (elution with 2% methanol in DCM) to afford {(R)-2-[(E)-3-(5-cyano-2-methoxy-phenyl)-acryloylamino]-3-[4-(4-fluoro-phenoxy)-piperidin-1-yl]-propyl}-carbamic acid tert-butyl ester. [MH]+ 553.0.
후처리
- washwashed with saturated aqueous NaHCO3, water and brine
- dry with materialThe DCM phase is dried over MgSO4
- customevaporated
- customThe crude product is purified by flash silica chromatography (elution with 2% methanol in DCM)
출처 및 근거
- ORD 기록
- ord-a4efb02a2a564838af9b4212ee5e93b8
- 출처 데이터셋
- uspto-grants-2006_04
- 특허 번호
- US07034042B2
연결된 노트
불러오는 중…